Oliver Sexton Joins Investor Panels at IBioIC & Biotech & Money 2017 Conferences

IBioIC Innovation & Investment – Glasgow

On 26 January 2017, UKI2S Investment Manager Oliver Sexton will chair the Innovation Investment panel to provide an insight into the opportunities available for startups. The discussion will include local biotech start-up companies sharing their experiences in gaining investment. Panelists include Abou Diallo, Business Development Manager, Horizon Proteins; Jim Laird, CEO, 3f bio; Sandy Dobbie, Director, Cogency Chemical Consultants; Ged Russell, Director, Vireol Management Services; and Josko Bobanovic, Sofinnova. IBioIC’s third annual conference brings together more than 300 bio-based professionals, academics and students from across the UK and Europe for this two-day conference demonstrating the very best of Scotland’s capabilities in the IB sector and the work happening with our UK and international colleagues.

Additional IBioIC event details may be found here: https://www.ibioic.com/2017_Conference_Info.htm

Biotech & Money 2017 Strengthening UK & EU Seed Funding – London

On 7 February 2017 in London, Oliver will speak on the “Strengthening UK and EU seed funding” panel at the 3rd annual Biotech and Money event. Biotech and Money provides the education, strategies and solutions life science companies needed to enable more effective funding, investment, business planning and partnering within their businesses.

Oliver will be joined on the panel by a number of prominent UK and European seed funds to discuss the dynamic that presently exists across Europe and debate what it will take to create a EU seed capital market. Panelists include Christina Takke, Co-Founder and Managing Director, V-Bio Ventures;  Viktor Drvota, CIO, Karolinska Development; Michael Brandkamp, Managing Director, High-Tech Gründerfonds; and  Søren Møller, Managing Investment Director, Novo Seeds.

Biotech & Money 2017 event details may be found here:  http://www.biotechandmoney.com/london